WJ Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
WJ Financial Advisors's NVO Position: Q2 2026 in Review
WJ Financial Advisors reduced its Novo Nordisk (NVO) stake by 0.6% in Q2 2026, selling an estimated $3.22K and leaving 12,400 shares worth $594K. The position accounts for 0.44% of the portfolio, ranked #64.
WJ Financial Advisors first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $614K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- WJ Financial Advisors held 12,400 shares of Novo Nordisk worth $594K as of Q2 2026.
- WJ Financial Advisors sold 75 Novo Nordisk shares in Q2 2026, an estimated $3.22K.
- Novo Nordisk made up 0.44% of WJ Financial Advisors's portfolio in Q2 2026, its #64 holding.
- WJ Financial Advisors first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
- WJ Financial Advisors's Novo Nordisk position peaked at $614K in Q4 2025.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on WJ Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.